Raffaele Colombo/LinkedIn
Nov 21, 2024, 14:41
Raffaele Colombo: Upcoming early-phase ADC data at ASH24
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a recent article on X:
“Upcoming early-phase ADC data at ASH24 (including two interesting preclinical ADCs) 66th ASH Annual Meeting (December 7-10, 2024), full program.
Note: late-breaking abstracts available online on November 25.”
Raffaele Colombo, a leading figure in the pharmaceutical industry is the Associate Director of Medicinal Chemistry at Zymeworks Inc.. His leadership and scientific acumen drive the discovery and optimization of novel drug candidates and advancing the treatment landscape for various diseases.
More posts featuring Raffaele Colombo.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25
Nov 21, 2024, 12:57
Nov 21, 2024, 12:54
Nov 21, 2024, 12:49
Nov 21, 2024, 12:36